References
- Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45–56. doi:https://doi.org/10.1038/ni.3049.
- Peebles RS, Aronica MA. Proinflammatory pathways in the pathogenesis of asthma. Clin Chest Med. 2019;40(1):29–50. doi:https://doi.org/10.1016/j.ccm.2018.10.014.
- Schleich FN, Chevremont A, Paulus V, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J. 2014;44(1):97–108. doi:https://doi.org/10.1183/09031936.00201813.
- Ilmarinen P, Kankaanranta H. Eosinophil apoptosis as a therapeutic target in allergic asthma. Basic Clin Pharmacol Toxicol. 2014;114(1):109–117. doi:https://doi.org/10.1111/bcpt.12163.
- Comhair SA, Erzurum SC. Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2010;12(1):93–124. doi:https://doi.org/10.1089/ars.2008.2425.
- Dworski R, Simon H-U, Hoskins A, Yousefi S. Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol. 2011;127(5):1260–1266. doi:https://doi.org/10.1016/j.jaci.2010.12.1103.
- Cunha A, Porto B, Nuñez N, et al. Extracellular DNA traps in bronchoalveolar fluid from a murine eosinophilic pulmonary response. Allergy. 2014;69(12):1696–1700. doi:https://doi.org/10.1111/all.12507.
- Miyata J, Fukunaga K, Kawashima Y, Ohara O, Arita M. Cysteinyl leukotriene metabolism of human eosinophils in allergic disease. Allergol Int. 2020;69(1):28–34. doi:https://doi.org/10.1016/j.alit.2019.06.002.
- Peters-Golden M, Brock T. 5-lipoxygenase and FLAP. Prostaglandins Leukot Essent Fatty Acids. 2003;69(2–3):99–109. doi:https://doi.org/10.1016/S0952-3278(03)00070-X.
- Trinh HKT, Lee S-H, Cao TBT, Park H-S. Asthma pharmacotherapy: an update on leukotriene treatments. Expert Rev Respir Med. 2019;13(12):1169–1178. doi:https://doi.org/10.1080/17476348.2019.1670640.
- Oyoshi MK, He R, Li Y, et al. Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation. Immunity. 2012;37(4):747–758. doi:https://doi.org/10.1016/j.immuni.2012.06.018.
- Sezin T, Krajewski M, Wutkowski A, et al. The leukotriene B4 and its receptor BLT1 act as critical drivers of neutrophil recruitment in murine bullous pemphigoid-like epidermolysis bullosa acquisita. J Invest Dermatol. 2017;137(5):1104–1113. doi:https://doi.org/10.1016/j.jid.2016.12.021.
- Thompson-Souza GA, Gropillo I, Neves JS. Cysteinyl leukotrienes in eosinophil biology: functional roles and therapeutic perspectives in eosinophilic disorders. Front Med (Lausanne). 2017;4:106. doi:https://doi.org/10.3389/fmed.2017.00106.
- Han B, Luo G, Shi Z-Z, et al. Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo. Am J Pathol. 2002;161(2):481–490. doi:https://doi.org/10.1016/s0002-9440(10)64204-6.
- Melo RC, Weller PF. Unraveling the complexity of lipid body organelles in human eosinophils. J Leukoc Biol. 2014;96(5):703–712. doi:https://doi.org/10.1189/jlb.3RU0214-110R.
- Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol. 2004;173(3):1503–1510. doi:https://doi.org/10.4049/jimmunol.173.3.1503.
- Lynch KR, O'Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 1999;399(6738):789–793. doi:https://doi.org/10.1038/21658.
- Jo-Watanabe A, Okuno T, Yokomizo T. The role of leukotrienes as potential therapeutic targets in allergic disorders. Int J Mol Sci. 2019;20(14):3580. doi:https://doi.org/10.3390/ijms20143580.
- Yousefi S, Gold JA, Andina N, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med. 2008;14(9):949–953. doi:https://doi.org/10.1038/nm.1855.
- Ueki S, Konno Y, Takeda M, et al. Eosinophil extracellular trap cell death-derived DNA traps: their presence in secretions and functional attributes. J Allergy Clin Immunol. 2016;137(1):258–267. doi:https://doi.org/10.1016/j.jaci.2015.04.041.
- Muniz VS, Silva JC, Braga YA, et al. Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus. J Allergy Clin Immunol. 2018;141(2):571–585. e7. doi:https://doi.org/10.1016/j.jaci.2017.07.048.
- da Cunha AA, Nuñez NK, de Souza RG, et al. Recombinant human deoxyribonuclease therapy improves airway resistance and reduces DNA extracellular traps in a murine acute asthma model. Exp Lung Res. 2016;42(2):66–74. doi:https://doi.org/10.3109/01902148.2016.1143537.
- Choi Y, Kim YM, Lee HR, et al. Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma. Allergy. 2020;75(1):95–103. doi:https://doi.org/10.1111/all.13997.
- Silveira JS, Antunes GL, Kaiber DB, et al. Reactive oxygen species are involved in eosinophil extracellular traps release and in airway inflammation in asthma. J Cell Physiol. 2019;234(12):23633–23646. doi:https://doi.org/10.1002/jcp.28931.
- Silveira JS, Antunes GL, Kaiber DB, et al. Autophagy induces eosinophil extracellular traps formation and allergic airway inflammation in a murine asthma model. J Cell Physiol. 2020;235(1):267–280. doi:https://doi.org/10.1002/jcp.28966.
- Douda DN, Grasemann H, Pace-Asciak C, Palaniyar N. A lipid mediator hepoxilin A3 is a natural inducer of neutrophil extracellular traps in human neutrophils. Mediators Inflamm. 2015;2015:520871. doi:https://doi.org/10.1155/2015/520871.
- Shishikura K, Horiuchi T, Sakata N, et al. Prostaglandin E2 inhibits neutrophil extracellular trap formation through production of cyclic AMP. Br J Pharmacol. 2016;173(2):319–331. doi:https://doi.org/10.1111/bph.13373.
- Lefrançais E, Mallavia B, Zhuo H, Calfee CS, Looney MR. Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI Insight. 2018;3(3). doi:https://doi.org/10.1172/jci.insight.98178.
- Wei F, Gong W, Wang J, et al. Role of the lipoxin A4 receptor in the development of neutrophil extracellular traps in Leishmania infantum infection. Parasit Vectors. 2019;12(1):275–210. doi:https://doi.org/10.1186/s13071-019-3530-8.
- Antunes GL, Silveira JS, Kaiber DB, et al. Cholinergic anti-inflammatory pathway confers airway protection against oxidative damage and attenuates inflammation in an allergic asthma model. J Cell Physiol. 2020;235(2):1838–1849. doi:https://doi.org/10.1002/jcp.29101.
- Masid-de-Brito D, Queto T, Gaspar-Elsas MIC, Xavier-Elsas P. Roles of 5-lipoxygenase and cysteinyl-leukotriene type 1 receptors in the hematological response to allergen challenge and its prevention by diethylcarbamazine in a murine model of asthma. Mediators Inflamm. 2014;2014:403970. doi:https://doi.org/10.1155/2014/403970.
- Luz RA, Xavier-Elsas P, de Luca B, et al. 5-lipoxygenase-dependent recruitment of neutrophils and macrophages by eotaxin-stimulated murine eosinophils. Mediators Inflamm. 2014;2014:102160. doi:https://doi.org/10.1155/2014/102160.
- Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg J. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol (1985). 1992;72(1):168–178. doi:https://doi.org/10.1152/jappl.1992.72.1.168.
- Zosky GR, Janosi TZ, Adamicza A, et al. The bimodal quasi-static and dynamic elastance of the murine lung. J Appl Physiol (1985). 2008;105(2):685–692. doi:https://doi.org/10.1152/japplphysiol.90328.2008.
- Choi Y, Lee Y, Park HS. Which factors associated with activated eosinophils contribute to the pathogenesis of aspirin-exacerbated respiratory disease? Allergy Asthma Immunol Res. 2019;11(3):320–329. doi:https://doi.org/10.4168/aair.2019.11.3.320.
- Choi Y, Sim S, Park HS. Distinct functions of eosinophils in severe asthma with type 2 phenotype: clinical implications. Korean J Intern Med. 2020;35(4):823–833. doi:https://doi.org/10.3904/kjim.2020.022.
- Wu AY, Chik SC, Chan AW, Li Z, Tsang KW, Li W. Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma. Clin Exp Allergy. 2003;33(3):359–366. doi:https://doi.org/10.1046/j.1365-2222.2003.01615.x.
- Paruchuri S, Tashimo H, Feng C, et al. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med. 2009;206(11):2543–2555. doi:https://doi.org/10.1084/jem.20091240.
- Choi Y, Le Pham D, Lee D-H, Lee S-H, Kim S-H, Park H-S. Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma. Exp Mol Med. 2018;50(8):1–8. doi:https://doi.org/10.1038/s12276-018-0136-8.
- Malm-Erjefält M, Persson CG, Erjefält JS. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol. 2001;24(3):352–359. doi:https://doi.org/10.1165/ajrcmb.24.3.4357.
- Chu DK, Jimenez-Saiz R, Verschoor CP, et al. Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo. J Exp Med. 2014;211(8):1657–1672. doi:https://doi.org/10.1084/jem.20131800.
- Neves JS, Radke AL, Weller PF. Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules. J Allergy Clin Immunol. 2010;125(2):477–482. doi:https://doi.org/10.1016/j.jaci.2009.11.029.
- Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol. 1995;154(9):4749–4758.
- Henderson WR, Jr., Lewis DB, Albert RK, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med. 1996;184(4):1483–1494. doi:https://doi.org/10.1084/jem.184.4.1483.
- Dartt DA, Hodges RR, Li D, Shatos MA, Lashkari K, Serhan CN. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol. 2011;186(7):4455–4466. doi:https://doi.org/10.4049/jimmunol.1000833.
- Shirasaki H, Kanaizumi E, Seki N, Himi T. Leukotriene E4 induces MUC5AC release from human airway epithelial NCI-H292 cells. Allergol Int. 2015;64(2):169–174. doi:https://doi.org/10.1016/j.alit.2014.11.002.
- Accomazzo MR, Rovati GE, Viganò T, et al. Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent. Am J Respir Crit Care Med. 2001;163(1):266–272. doi:https://doi.org/10.1164/ajrccm.163.1.9912019.
- Mori V, Oliveira MA, Vargas MHM, et al. Input respiratory impedance in mice: comparison between the flow-based and the wavetube method to perform the forced oscillation technique. Physiol Meas. 2017;38(6):992–1005. doi:https://doi.org/10.1088/1361-6579/aa6b75.
- Schaible AM, Filosa R, Krauth V, et al. The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in vivo. Biochem Pharmacol. 2016;112:60–71. doi:https://doi.org/10.1016/j.bcp.2016.04.019.
- Kubavat AH, Khippal N, Tak S, et al. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma. Am J Ther. 2013;20(2):154–162. doi:https://doi.org/10.1097/MJT.0b013e318254259b.
- Cowburn AS, Holgate ST, Sampson AP. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils. J Immunol. 1999;163(1):456–465.
- Amrani Y, Moore PE, Hoffman R, Shore SA, Panettieri Ra J. Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. Am J Respir Crit Care Med. 2001;164(11):2098–2101. doi:https://doi.org/10.1164/ajrccm.164.11.2108005.
- Thivierge M, Stanková J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol. 2001;167(5):2855–2860. doi:https://doi.org/10.4049/jimmunol.167.5.2855.
- Early SB, Barekzi E, Negri J, Hise K, Borish L, Steinke JW. Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells. Am J Respir Cell Mol Biol. 2007;36(6):715–720. doi:https://doi.org/10.1165/rcmb.2006-0252OC.
- Chen WJ, Liaw SF, Lin CC, Lin MW, Chang FT. Effects of zileuton on airway smooth muscle remodeling after repeated allergen challenge in brown Norway rats. Respiration. 2013;86(5):421–429. doi:https://doi.org/10.1159/000353427.
- Simon D, Hoesli S, Roth N, Staedler S, Yousefi S, Simon HU. Eosinophil extracellular DNA traps in skin diseases. J Allergy Clin Immunol. 2011;127(1):194–199. doi:https://doi.org/10.1016/j.jaci.2010.11.002.
- Granger V, Taillé C, Roach D, et al. Circulating neutrophil and eosinophil extracellular traps are markers of severe asthma. Allergy. 2020;75(3):699–702. doi:https://doi.org/10.1111/all.14059.
- Zeiger RS, Szefler SJ, Phillips BR, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol. 2006;117(1):45–52. doi:https://doi.org/10.1016/j.jaci.2005.10.012.
- Rabinovitch N, Graber NJ, Chinchilli VM, et al. Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma. J Allergy Clin Immunol. 2010;126(3):545–551. doi:https://doi.org/10.1016/j.jaci.2010.07.008.